Literature DB >> 25034115

A clinical, radiologic, and immunopathologic study of five periorbital intraosseous cavernous vascular malformations.

Xiang Q Werdich1, Frederick A Jakobiec2, Hugh D Curtin3, Aaron Fay4.   

Abstract

PURPOSE: To correlate the clinical, radiographic, histopathologic, and immunohistochemical features of 5 primary periorbital intraosseous cavernous vascular malformations.
DESIGN: Retrospective interventional case series.
METHODS: Clinical and operative records and radiographic images were reviewed. Histopathologic slides were evaluated with hematoxylin-eosin, trichrome, and elastin stains. Immunohistochemical studies were performed with a spectrum of monoclonal antibodies directed at antigens of vascular cells.
RESULTS: Three men and 2 women ranged in age from 36 to 64 years. Vision was unaffected and there was no proptosis or globe displacement. The slow-growing lesions measured 13-25 mm in greatest diameter (mean 16.4 mm). Computed tomographic studies revealed that 2 lesions were situated in the maxillary bone, 2 in the frontal, and 1 in the zygoma, all anteriorly and with circumscribed, lucent, honeycombed, or sunburst characteristics. Histopathologically the lesions were composed of cavernous or telangiectatic channels; 1 showed advanced fibrotic vascular involution. Immunohistochemistry demonstrated CD31/34 positivity for vascular endothelium and D2-40 negativity for lymphatic endothelium. A typically thin mural myofibroblastic cuff was smooth muscle actin positive, weakly calponin positive, and desmin negative. Glucose transporter-1 and Ki-67 were negative in the endothelium.
CONCLUSIONS: Intraosseous vascular lesions resemble orbital cavernous venous malformations (not true hemangiomas), except that their vascular walls are thinner owing to the constraints imposed by neighboring bone spicules, which limit the amount of interstitium from which mural myofibroblasts can be recruited. The bony trabeculae conferred the honeycomb or sunburst appearances observed radiographically. En bloc excision of these lesions was successful and avoided complications (mean follow-up, 46 months).
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25034115     DOI: 10.1016/j.ajo.2014.07.004

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Freiburg neuropathology case conference: periorbital bone lesion causing proptosis in a 31-year-old patient.

Authors:  C A Taschner; S Brendecke; M Campos; H Urbach; N Lützen; M Prinz
Journal:  Clin Neuroradiol       Date:  2014-11-01       Impact factor: 3.649

2.  Loss-of-Function Mutations in ELMO2 Cause Intraosseous Vascular Malformation by Impeding RAC1 Signaling.

Authors:  Arda Cetinkaya; Jingwei Rachel Xiong; İbrahim Vargel; Kemal Kösemehmetoğlu; Halil İbrahim Canter; Ömer Faruk Gerdan; Nicola Longo; Ahmad Alzahrani; Mireia Perez Camps; Ekim Zihni Taskiran; Simone Laupheimer; Lorenzo D Botto; Eeswari Paramalingam; Zeliha Gormez; Elif Uz; Bayram Yuksel; Şevket Ruacan; Mahmut Şamil Sağıroğlu; Tokiharu Takahashi; Bruno Reversade; Nurten Ayse Akarsu
Journal:  Am J Hum Genet       Date:  2016-07-28       Impact factor: 11.025

Review 3.  Intraosseous Venous Malformations of the Head and Neck.

Authors:  S B Strauss; J M Steinklein; C D Phillips; D R Shatzkes
Journal:  AJNR Am J Neuroradiol       Date:  2022-07-21       Impact factor: 4.966

4.  Vertebral Intraosseous Vascular Malformations in a Familial Cerebral Cavernous Malformation Population: Prevalence, Histologic Features, and Associations With CNS Disease.

Authors:  Steven R Tandberg; Thèrése Bocklage; Mary R Bartlett; Leslie A Morrison; Jeffrey Nelson; Blaine L Hart
Journal:  AJR Am J Roentgenol       Date:  2019-12-11       Impact factor: 3.959

5.  Computer guided resection and reconstruction of intra-osseous zygomatic hemangioma: Case report and systematic review of literature.

Authors:  Ahmed Talaat Temerek; Sherif Ali; Mohamed Farid Shehab
Journal:  Int J Surg Case Rep       Date:  2019-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.